The company received $441,437 from the foundation to miniaturize its molecular point-of-care test for HIV viral load.
Even as COVID-19 vaccines are being deployed around the world, the clinical laboratory will continue to play a major role this year helping to control the pandemic by diagnosing new infections and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results